Abstract

BackgroundIn 2014, the ACR launched the Rheumatology Informatics System for Effectiveness (RISE), a national electronic health record (EHR)-enabled registry. RISE passively collects data from EHRs of participating practices, provides advanced...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Rheumatology Informatics System for Effectiveness: A National Informatics-Enabled Registry for Quality Improvement.
Megan Clowse ... Salahuddin Kazi
Arthritis care & research | VOL. 68
Megan Clowse, et. al.Megan Clowse ... Salahuddin Kazi
28 Nov 2016
FRI0524 THE ACR’S RHEUMATOLOGY INFORMATICS SYSTEM FOR EFFECTIVENESS (RISE) REGISTRY SUPPORTS SMALL RHEUMATOLOGY PRACTICES FOR FEDERAL QUALITY REPORTING PROGRAM
J Yazdany ... Z Izadi
-
J Yazdany, et. al.J Yazdany ... Z Izadi
01 Jun 2020
Development of a Natural Language Processing System for Extracting Rheumatoid Arthritis Outcomes From Clinical Notes Using the National Rheumatology Informatics System for Effectiveness Registry.
Zara Izadi ... Matthew C Baker
Arthritis care & research | VOL. 75
Zara Izadi, et. al.Zara Izadi ... Matthew C Baker
31 Oct 2022
The Relationship Between Electronic Health Record System and Performance on Quality Measures in the American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) Registry: Observational Study.
Gabriela Schmajuk ... Jing Li
JMIR medical informatics | VOL. 9
Gabriela Schmajuk, et. al.Gabriela Schmajuk ... Jing Li
12 Nov 2021
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations
Myrto Kostopoulou ... Antonis Fanouriakis
Annals of the Rheumatic Diseases | VOL. -
Myrto Kostopoulou, et. al.Myrto Kostopoulou ... Antonis Fanouriakis
22 May 2024
View more papers